Market Place
Sourcing Support
Pfizer And Arvinas Give Disappointing Breast Cancer Drug To Rigel
12 May 2026 //
ENDPOINTS
Pfizer`s Albert Bourla Says He Has No Mega-Merger Plans
05 May 2026 //
ENDPOINTS
Pfizer Is A 2029 Story But Q126 Lays Foundation For Growth
05 May 2026 //
BIOSPACE
FDA Approves Pfizer-Arvinas Breast Cancer Drug Despite Weak Data
04 May 2026 //
ENDPOINTS
US FDA Approves Pfizer, Arvinas` Breast Cancer Drug
01 May 2026 //
REUTERS
Pfizer Settles With Generic Drugmakers To Protect Blockbuster
29 Apr 2026 //
BIOSPACE
Pfizer`s ELREXFIO Boosts Survival in Relapsed Myeloma
29 Apr 2026 //
BUSINESSWIRE
Pfizer`s Blood Cancer Drug Meets Main Goal In Late-Stage Trial
29 Apr 2026 //
REUTERS HEALTHCARE
Pfizer Reaches Three Settlement Agreements for VYNDAMAX
28 Apr 2026 //
BUSINESSWIRE
Hikma Announces Settlement Agreement For Vyndamax (Tafamidis)
28 Apr 2026 //
FIRSTWORD PHARMA
Pfizer Secures Deals to Block Heart Drug Generics Until 2030
28 Apr 2026 //
REUTERS
Pfizer Delays Patent Cliff For Blockbuster Vyndamax
28 Apr 2026 //
ENDPOINTS
Relay Report Clinical Data Supporting Triplet Combo in MBC Cancer
27 Apr 2026 //
GLOBENEWSWIRE
Pfizer Ends Early PD-L1 Asset, Gains Clinical Success In Cancer
24 Apr 2026 //
BIOSPACE
Helus Pharma Ousts Pfizer`s A. Baum as CEO After 2 Months
24 Apr 2026 //
ENDPOINTS NEWS
BMS, Pfizer Offer Eliquis Via Mark Cuban`s Cost Plus Drugs
24 Apr 2026 //
FIRSTWORD PHARMA
Pfizer Cans Work On Next-Gen Conjugate In Cancer Patients
23 Apr 2026 //
FIERCE BIOTECH
Pfizer Declares Its Second-Quarter 2026 Dividend
22 Apr 2026 //
BUSINESSWIRE
Pfizer`s Chief Strategist Andrew Baum To Step Down: Reports
21 Apr 2026 //
FIERCE PHARMA
Pfizer Highlights Oncology Innovation At ASCO 2026
21 Apr 2026 //
PHARMIWEB
Pfizer Recruits A Former Angel For Latest Mission Against Cancer
15 Apr 2026 //
FIERCE PHARMA
FDA Cracks Down on Drug Ads with 3 Untitled Letters
15 Apr 2026 //
RAPS
Pfizer Rebuked By FDA For Misleading Adcetris Ads On Facebook
14 Apr 2026 //
FIERCE PHARMA
IDEAYA and Servier`s Eye Cancer Drug Meets Trial Goal
13 Apr 2026 //
REUTERS
BCAN Taps Ferring, Astellas/Pfizer for 2026 Initiatives
09 Apr 2026 //
GLOBENEWSWIRE
Pfizer Invites Shareholders to April 23 Virtual Meeting
09 Apr 2026 //
BUSINESSWIRE
Pfizer Closes Down `Underutilized` Office Space In California
08 Apr 2026 //
FIERCE PHARMA
Novavax Boosts `Amplification Strategy` Through Sanofi, Pfizer
06 Apr 2026 //
FIERCE PHARMA
Pfizer, BioNTech Halt US COVID Vaccine Trial Over Safety Issues
02 Apr 2026 //
BIOSPACE
Poland, Romania Ordered To Pay $2.2B In Pfizer COVID Vax Suit
02 Apr 2026 //
FIERCE PHARMA
Why Valneva CEO Remains Bullish On Pfizer-Partnered Lyme Vaccine
01 Apr 2026 //
FIERCE BIOTECH
Pfizer, BioNTech halt COVID vaccine study after struggles
01 Apr 2026 //
REUTERS
Pfizer Schedules May 5 Analyst Conference Call Webcast
24 Mar 2026 //
BUSINESSWIRE
Pfizer-Valneva Lyme disease shot shows more than 70% efficacy
23 Mar 2026 //
REUTERS
Pfizer Recommends Shareholders Reject The Mini-Tender Offer
20 Mar 2026 //
BUSSINESSWIRE
Earendil Labs Secures $787M To Expand AI-Driven Biologics R&D
20 Mar 2026 //
PR NEWSWIRE
Pfizer Drops Another Early Cancer Candidate From Seagen
19 Mar 2026 //
FIERCE BIOTECH
Pfizer Eyes Earlier Talzenna Use After Ph. 3 Prostate Cancer Win
19 Mar 2026 //
FIERCE PHARMA
Pfizer’s Ibrance Heir Reduces Risk of Death in Ph 2 Breast Cancer
17 Mar 2026 //
BIOSPACE
Pfizer CEO Albert Bourla Earns 2025 Pay Bump To $27.6M
13 Mar 2026 //
FIERCE PHARMA
Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug
12 Mar 2026 //
REUTERS
Pfizer`s Phase 2 Study Of Trispecific Antibody Positive
09 Mar 2026 //
BUSSINESSWIRE
Pfizer Ramps Up Plans For Trispecific After Ph. 2 Eczema Win
09 Mar 2026 //
PRESS RELEASE
China Signs Off On Pfizer, Sciwind`s GLP-1 Weight Loss Drug
06 Mar 2026 //
FIERCE PHARMA
China Approves Pfizer GLP-1 Drug for Weight Loss
06 Mar 2026 //
REUTERS
Former Employees Open To Returning To Layoff Companies
05 Mar 2026 //
BIOSPACE
How Jeff Legos Builds Pfizer`s Oncology Future
04 Mar 2026 //
FIERCE BIOTECH
Pfizer CEO Albert Bourla Levels Criticism Of CBER`s Vinay Prasad
03 Mar 2026 //
FIERCE PHARMA
Merck, Pfizer`s Bladder Cancer Drug Combo Redefines Standard
02 Mar 2026 //
BIOSPACE
Padcev-Keytruda Combo Wins in MIBC Amid Evolving Landscape
28 Feb 2026 //
FIERCE PHARMA
PADCEV + Keytruda Cuts Recurrence, Death Risk in Bladder Cancer
27 Feb 2026 //
PHARMIWEB
ViiV Health: Long-Acting Cabenuva Maintains HIV Control in Teens
26 Feb 2026 //
PHARMIWEB
Pfizer Boosts Beam Gene Editor Post Hemophilia Therapy Withdrawal
26 Feb 2026 //
BIOSPACE
FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination
26 Feb 2026 //
FDA
After Gene Therapy Exit, Pfizer Licenses Beam Gene Editing Asset
25 Feb 2026 //
FIERCE BIOTECH
FDA Approves Pfizer`s BRAFTOVI for First-Line mCRC Treatment
25 Feb 2026 //
PHARMIWEB
Pfizer in Diabetes Drug Deal with Sciwind Biosciences
24 Feb 2026 //
BLOOMBERG
Pfizer Hosts Webcast For Healthcare Conference Discussion
23 Feb 2026 //
BUSINESSWIRE
Viiv Pharma Unveils Long-Acting HIV Breakthroughs At CROI 2026
17 Feb 2026 //
BUSINESSWIRE
Madrigal Pens $4.4B Deal For siRNA Drugs In Fresh Rezdiffra Play
12 Feb 2026 //
FIERCE BIOTECH
